JAZZ financial statements
The full income statement, balance sheet, and cash-flow statement for Jazz Pharmaceuticals plc Common Stock (Ireland) (JAZZ), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 4.27B YoY+4.9% | 4.07B YoY+6.1% | 3.83B YoY+4.8% | 3.66B YoY+18.3% | 3.09B YoY+30.9% | |
| Research & development | 783M YoY-11.5% | 884M YoY+4.0% | 850M YoY+43.9% | 590M YoY+16.7% | 506M YoY+50.8% | |
| Selling, general & administrative | 1.81B YoY+30.6% | 1.39B YoY+3.1% | 1.34B YoY-5.2% | 1.42B YoY-2.4% | 1.45B YoY+69.9% | |
| Amortization of intangibles | 655M YoY+4.4% | 627M YoY+3.1% | 608M YoY+1.5% | 599M YoY+14.0% | 526M YoY+102.5% | |
| Operating income | -430M YoY-160.0% | 717M YoY+23.9% | 579M YoY+983.0% | -65.5M YoY-138.5% | 170M YoY-55.0% | |
| Interest expense | — | — | 32.8M YoY+0.0% | 32.8M YoY-63.5% | 89.9M YoY+2.6% | |
| Interest & investment income | 85.8M YoY-19.3% | 106M YoY+63.3% | 65.1M YoY+466.1% | 11.5M YoY+538.9% | 1.80M YoY-83.8% | |
| Equity-method income | -732K YoY+55.9% | -1.66M YoY+44.8% | -3.01M YoY+69.7% | -9.92M YoY-1289.5% | -714K YoY+75.9% | |
| Pre-tax income | -628M YoY-233.5% | 470M YoY+57.9% | 298M YoY+179.9% | -373M YoY-230.4% | -113M YoY-141.0% | |
| Income tax | -272M YoY-198.0% | -91.4M YoY+23.8% | -120M YoY+24.4% | -159M YoY-173.4% | 216M YoY+544.8% | |
| Net income | -356M YoY-163.6% | 560M YoY+35.0% | 415M YoY+285.1% | -224M YoY+32.0% | -330M YoY-238.2% | |
-$5.84 YoY-167.5% | $8.65 YoY+41.8% | $6.10 YoY+270.4% | -$3.58 YoY+35.1% | -$5.52 YoY-230.8% | ||
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
4.17B YoY-10.0% | 4.63B YoY+34.7% | 3.44B YoY+31.8% | 2.61B YoY-0.2% | 2.61B YoY-8.0% | ||
11.7B YoY-2.9% | 12.0B YoY+5.4% | 11.4B YoY+5.2% | 10.8B YoY-11.9% | 12.3B YoY+88.2% | ||
2.24B YoY+115.9% | 1.04B YoY-32.4% | 1.54B YoY+64.7% | 933M YoY+15.3% | 809M YoY+23.8% | ||
| Long-term debt | 4.33B YoY-28.8% | 6.08B YoY+19.0% | 5.11B YoY-10.3% | 5.69B YoY-5.4% | 6.02B YoY+225.6% | |
| Deferred revenue (non-current) | — | — | — | 0.00 YoY-100.0% | 463K YoY-80.0% | |
| Non-current lease liability | 50.9M YoY+30.7% | 38.9M YoY-34.3% | 59.2M YoY-17.6% | 71.8M YoY-17.6% | 87.2M YoY-37.7% | |
| Operating lease liability (total) | 65.2M YoY+22.3% | 53.3M YoY-31.9% | 78.2M YoY-10.5% | 87.4M YoY-14.8% | 103M YoY-33.6% | |
| Finance lease liability (total) | 3.88M YoY-22.6% | 5.01M YoY-8.4% | 5.47M YoY-2.2% | 5.59M YoY-16.2% | 6.67M | |
| Finance lease liability | 3.44M YoY-24.6% | 4.56M YoY-9.5% | 5.04M YoY-3.3% | 5.21M YoY-16.9% | 6.27M | |
| Deferred tax liabilities | 595M YoY-12.2% | 677M YoY-20.2% | 848M YoY-10.2% | 944M YoY-27.4% | 1.30B YoY+897.4% | |
| Other non-current liabilities | 124M YoY+43.6% | 86.6M YoY-17.3% | 105M YoY-1.9% | 107M YoY-8.7% | 117M YoY+15.7% | |
4.32B YoY+5.5% | 4.09B YoY+9.5% | 3.74B YoY+21.1% | 3.09B YoY-22.2% | 3.97B YoY+8.3% | ||
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
1.36B YoY-2.9% | 1.40B YoY+27.8% | 1.09B YoY-14.1% | 1.27B YoY+63.4% | 779M YoY-13.5% | ||
-1.51B YoY-197.1% | -508M YoY-211.7% | -163M YoY+63.5% | -446M YoY+91.4% | -5.21B YoY-417.2% | ||
-873M YoY-4357.1% | 20.5M YoY+106.7% | -305M YoY+42.3% | -529M YoY-113.3% | 3.97B YoY+651.9% | ||
| FX effect on cash | 6.55M YoY+491.3% | -1.68M YoY-247.3% | 1.14M YoY+118.3% | -6.22M YoY-94.0% | -3.21M YoY-957.5% | |
| Net change in cash | -1.02B YoY-212.6% | 907M YoY+45.1% | 625M YoY+115.4% | 290M YoY+162.2% | -466M YoY-210.9% | |
| Interest paid | 249M YoY-21.0% | 315M YoY-5.5% | 333M YoY+23.1% | 271M YoY+95.8% | 138M YoY+225.6% | |
| Income taxes paid | 122M YoY+6.0% | 115M YoY-35.4% | 178M YoY+87.9% | 94.7M YoY-65.1% | 271M YoY+19.6% | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 10.5B YoY+39.9% | 7.48B YoY-3.4% | 7.74B YoY-22.8% | 10.0B YoY+27.5% | 7.87B YoY-15.4% | |
| P/E | — | 13.4× YoY-86.2% | 96.9× | — | — | |
| P/S | 2.5× YoY+33.4% | 1.8× YoY-9.9% | 2.0× YoY-27.1% | 2.8× YoY+10.1% | 2.5× YoY-35.4% | |
| P/B | 2.4× YoY+32.6% | 1.8× YoY-17.7% | 2.2× YoY-39.3% | 3.7× YoY+84.2% | 2.0× YoY-21.9% | |
| P/FCF | 8.1× YoY+46.5% | 5.5× YoY-11.6% | 6.2× YoY-33.1% | 9.3× YoY-11.2% | 10.5× YoY-0.3% | |
— | 7.5% YoY+625.3% | 1.0% | — | — | ||
12.4% YoY-31.7% | 18.2% YoY+13.1% | 16.1% YoY+49.4% | 10.7% YoY+12.6% | 9.5% YoY+0.3% | ||
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: JAZZ's SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn't file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all JAZZ filings on SEC EDGAR → Not investment advice.
